(Q36848232)
Statements
1 reference
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development (English)
1 reference
Spellberg B
1 reference
Miller LG
1 reference
Kuo MN
1 reference
Bradley J
1 reference
Scheld WM
1 reference
Edwards JE Jr
1 reference
1 June 2007
1 reference
1 reference
35
1 reference
3
1 reference
167-174
1 reference
Identifiers
1 reference
1 reference